Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,848 | 9,014 | 11,317 | 7,039 | 8,023 |
| TOTAL | $8,922 | $10,053 | $12,294 | $7,645 | $8,237 |
| Non-Current Assets | |||||
| Investments And Advances | 37 | 37 | 37 | 37 | 37 |
| Intangibles | 275 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 12 | 18 | 25 | 31 | 34 |
| TOTAL | $323 | $55 | $61 | $68 | $71 |
| Total Assets | $9,245 | $10,108 | $12,355 | $7,713 | $8,307 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 400 | 76 | 469 | 412 | 505 |
| Accrued Expenses | 599 | 268 | 317 | 391 | 274 |
| TOTAL | $1,013 | $365 | $815 | $831 | $810 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 3 | 3 |
| TOTAL | $N/A | $N/A | $N/A | $3 | $3 |
| Total Liabilities | $1,013 | $365 | $815 | $834 | $813 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,514 | 13,259 | 13,209 | 13,171 | 6,904 |
| Common Shares | 2 | 1 | 1 | 1 | 1 |
| Retained earnings | -70,191 | -66,085 | -63,886 | -60,410 | -58,750 |
| Other shareholders' equity | 11 | 12 | 9 | 9 | 26 |
| TOTAL | $8,232 | $9,743 | $11,540 | $6,879 | $7,494 |
| Total Liabilities And Equity | $9,245 | $10,108 | $12,355 | $7,713 | $8,307 |